Research Topics
Genomes and Genes
Species | Manon van EngelandSummaryCountry: The Netherlands Publications
| Collaborators
|
Detail Information
Publications
Colorectal cancer epigenetics: complex simplicityManon van Engeland
GROW School for Oncology and Developmental Biology, PO Box 616, 6200 Maastricht, The Netherlands
J Clin Oncol 29:1382-91. 2011..This review integrates recent data on epigenetic regulation of gene expression in CRC and describes how the understanding of these processes will alter the management of CRC...
Viewing the epigenetics of colorectal cancer through the window of folic acid effectsManon van Engeland
Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands
Cancer Prev Res (Phila) 3:1509-12. 2010..This perspective will place this study in context, looking at what it tells us and what it does not...
Associations of dietary methyl donor intake with MLH1 promoter hypermethylation and related molecular phenotypes in sporadic colorectal cancerStefan de Vogel
Department of Epidemiology, GROW, School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands
Carcinogenesis 29:1765-73. 2008....
Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?Eddy H J van Roon
Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands
BMC Cancer 10:180. 2010..As this type of colon cancer is associated with high ages, young patients bearing this type of malignancy are rare and could provide additional insight into the etiology of sporadic MSI-H colon cancer...
Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancerStefan de Vogel
Departments of Epidemiology, GROW School for Oncology and Developmental Biology, Nutrition and Toxicology Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands
Cancer Epidemiol Biomarkers Prev 18:3086-96. 2009..The incomplete overlap between CIMP, MLH1 hypermethylation, and microsatellite instability indicates that these related "methylation phenotypes" may not be similar and should be investigated separately...
N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancerVeerle Melotte
Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, The Netherlands
J Natl Cancer Inst 101:916-27. 2009..Here we examined the role of N-Myc downstream-regulated gene 4 (NDRG4) as a novel tumor suppressor and biomarker in colorectal cancer...
Dietary folate and APC mutations in sporadic colorectal cancerStefan de Vogel
Research Institute Growth and Development GROW, Department of Epidemiology, Maastricht University, Maastricht, The Netherlands
J Nutr 136:3015-21. 2006..These opposite results may indicate that folate enhances colorectal carcinogenesis through a distinct APC mutated pathway...
Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21Sarah Derks
Department of Pathology, Maastricht University Medical Center, The Netherlands
Carcinogenesis 30:1041-8. 2009..Only active epigenetic marks were detected for MBD1, CXXC1, SMAD4 and MBD2. This study demonstrates specific epigenetic silencing of DCC in CRC as a focal process not affecting neighboring genes on chromosomal region 18q21...
Identification of epigenetically silenced genes in tumor endothelial cellsDebby M E I Hellebrekers
Department of Pathology, Research Institute for Growth and Development, Maastricht University and University Hospital, Maastricht, The Netherlands
Cancer Res 67:4138-48. 2007....
Analytical sensitivity and stability of DNA methylation testing in stool samples for colorectal cancer detectionLinda J W Bosch
Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
Cell Oncol (Dordr) 35:309-15. 2012..In addition, we explored the detection of DNA methylation in fecal immunochemical test (FIT) fluid...
A let-7 microRNA SNP in the KRAS 3'UTR is prognostic in early-stage colorectal cancerKim M Smits
Departments of Pathology and Epidemiology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands
Clin Cancer Res 17:7723-31. 2011..Effects in early-stage CRC are however unknown. We studied KRAS-LCS6 genotype, hypothesizing that it might identify early-stage cases with a poor prognosis, and could potentially be used in therapy decision-making...
Early life exposure to famine and colorectal cancer risk: a role for epigenetic mechanismsLaura A E Hughes
Department of Epidemiology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands
PLoS ONE 4:e7951. 2009..Within the Netherlands Cohort Study on diet and cancer, we investigated the association between early life energy restriction and risk of subsequent CRC characterized by the (promoter) CpG island methylation phenotype (CIMP)...
Alcohol consumption and mutations or promoter hypermethylation of the von Hippel-Lindau gene in renal cell carcinomaLeo J Schouten
Department of Epidemiology, GROW School for Oncology and Developmental Biology, Maastricht University, P O Box 616, 6200 MD Maastricht, The Netherlands
Cancer Epidemiol Biomarkers Prev 17:3543-50. 2008..58; 95% CI, 0.34-0.99). In this study, a not statistically significant inverse association was observed between alcohol and renal cell cancer. There was no statistical significant heterogeneity by VHL mutation or methylation status...
Epigenetic regulation of tumor endothelial cell anergy: silencing of intercellular adhesion molecule-1 by histone modificationsDebby M E I Hellebrekers
Angiogenesis Laboratory, Research Institute for Growth and Development, Department of Pathology, Maastricht University and University Hospital, The Netherlands
Cancer Res 66:10770-7. 2006....
Alcohol consumption, alcohol dehydrogenase 1C (ADH1C) genotype, and risk of colorectal cancer in the Netherlands Cohort Study on diet and cancerBrenda W C Bongaerts
GROW School for Oncology and Developmental Biology, Department of Epidemiology, Maastricht University, The Netherlands
Alcohol 45:217-25. 2011..Nevertheless, the interaction deserves further investigation in larger genetic epidemiologic studies...
Integrated analysis of chromosomal, microsatellite and epigenetic instability in colorectal cancer identifies specific associations between promoter methylation of pivotal tumour suppressor and DNA repair genes and specific chromosomal alterationsSarah Derks
Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, 6200 MD, The Netherlands
Carcinogenesis 29:434-9. 2008..Therefore, we conclude that promoter methylation of pivotal tumour suppressor and DNA repair genes is associated with specific patterns of chromosomal changes in CRC, which are different from methylation patterns in MSI tumours...
Dietary folate intake and k-ras mutations in sporadic colon and rectal cancer in The Netherlands Cohort StudyMirian Brink
Research Institute Nutrition and Toxicology Research Institute Maastricht (NUTRIM, Department of Epidemiology, Maastricht University, Maastricht, The Netherlands
Int J Cancer 114:824-30. 2005..09), but inversely associated with G>A transitions (RR = 0.08, 95% CI = 0.01-0.53). Our data suggest that the effect of folate on rectal cancer risk is different for men and women and depends on the K-ras mutation status of the tumor...
Body size and colorectal cancer risk after 16.3 years of follow-up: an analysis from the Netherlands Cohort StudyLaura A E Hughes
Department of Epidemiology, Faculty of Health Medicine and Life Science, MaastrichtUniversity, Maastricht, The Netherlands
Am J Epidemiol 174:1127-39. 2011..Height was associated with risk of CRC, especially distal colon tumors (highest quintile vs. lowest: HR = 1.53, 95% CI: 1.03, 2.27; P-trend = 0.05), in women only...
DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FITLinda J W Bosch
Department of Pathology, VU University Medical Center, 1007 MB, Amsterdam, The Netherlands
Cancer Prev Res (Phila) 5:464-72. 2012..Adding PHACTR3 methylation to FIT increased sensitivity for CRC up to 15%. PHACTR3 is a new hypermethylated gene in CRC with a good performance in stool DNA testing and has complementary value to FIT...
Dietary folate, methionine, riboflavin, and vitamin B-6 and risk of sporadic colorectal cancerStefan de Vogel
Departments of Epidemiology, GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands
J Nutr 138:2372-8. 2008..This is the 2nd prospective cohort study in which vitamin B-6 intake was associated with increased risk of rectal tumors in women, which might suggest that this vitamin enhances rectal cancer in women...
The CpG island methylator phenotype in colorectal cancer: progress and problemsLaura A E Hughes
Dept of Epidemiology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, 6200MD Maastricht, The Netherlands
Biochim Biophys Acta 1825:77-85. 2012....
GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancerDebby M E I Hellebrekers
Departments of Pathology and Epidemiology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands
Clin Cancer Res 15:3990-7. 2009..Here, we evaluated GATA4/5 promoter methylation as potential biomarkers for noninvasive colorectal cancer detection, and investigated the role of GATA4/5 in colorectal cancer...
Body size, physical activity and risk of colorectal cancer with or without the CpG island methylator phenotype (CIMP)Laura A E Hughes
Department of Epidemiology, GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands
PLoS ONE 6:e18571. 2011..We investigated how body size and physical activity influence the risk of the CpG island methylator phenotype (CIMP) in colorectal cancer (CRC)...
Prognostic significance of Gremlin1 (GREM1) promoter CpG island hypermethylation in clear cell renal cell carcinomaIris J H van Vlodrop
Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, PO Box 616, 6200 MD Maastricht, The Netherlands
Am J Pathol 176:575-84. 2010..59, respectively). The strong correlation between GREM1 region iii promoter methylation and increased malignancy and its correlation with active angiogenesis indicates a role for GREM1 in ccRCC carcinogenesis and tumor angiogenesis...
VHL and HIF signalling in renal cell carcinogenesisMarcella M Baldewijns
Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands
J Pathol 221:125-38. 2010..In this review, we discuss existing and novel findings about RCC carcinogenesis, with subsequent clinical implications...
Different angiogenic potential in low and high grade sporadic clear cell renal cell carcinoma is not related to alterations in the von Hippel-Lindau geneMarcella M Baldewijns
Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands
Cell Oncol 31:371-82. 2009....
Promoter CpG island methylation markers in colorectal cancer: the road aheadMuriel X G Draht
Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands
Epigenomics 4:179-94. 2012..This review summarizes the current knowledge of hypermethylation biomarkers for CRC detection, progression and treatment outcome...
Childhood and adolescent energy restriction and subsequent colorectal cancer risk: results from the Netherlands Cohort StudyLaura A E Hughes
Department of Epidemiology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands
Int J Epidemiol 39:1333-44. 2010..Energy restriction during childhood and adolescence is suggested to lower colorectal cancer (CRC) risk. We investigated this in the Netherlands Cohort Study...
Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancerManon van Engeland
The Research Institute GROW, Department of Pathology, University Maastricht, 6200 MD Maastricht, The Netherlands
Cancer Res 63:3133-7. 2003..085). Despite the size limitations of this study, these data suggest that folate and alcohol intake may be associated with changes in promoter hypermethylation in CRC...
Genetic and epigenetic alterations in the von hippel-lindau gene: the influence on renal cancer prognosisKim M Smits
Departmens of Epidemiology, GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands
Clin Cancer Res 14:782-7. 2008..We have evaluated the influence of (epi)genetic alterations in VHL on cause-specific survival in clear-cell renal cell cancer (ccRCC) in a large, population-based group of cases...
Analysis of promoter CpG island hypermethylation in cancer: location, location, location!Iris J H van Vlodrop
Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands
Clin Cancer Res 17:4225-31. 2011..Here, we discuss the emerging evidence on the importance of the location of CpG dinucleotide hypermethylation in relation to gene expression and associations with clinicopathologic characteristics in cancer...
The adenoma hunt in colorectal cancer screening: defining the targetAnke H Sillars-Hardebol
Department of Pathology, VU University Medical Centre, Amsterdam, The Netherlands
J Pathol 226:1-6. 2012..Screening tests based on genomic changes that affect relevant biological and metabolic processes hold most promise in this respect...
Test performance of immunologic fecal occult blood testing and sigmoidoscopy compared with primary colonoscopy screening for colorectal advanced adenomasCarolina A J Khalid-de Bakker
Division of Gastroenterology Hepatology, Department of Internal Medicine, Maastricht University Medical Center, The Netherlands
Cancer Prev Res (Phila) 4:1563-71. 2011..This points to the existence of "low" FIT performance in subgroups and the need for more tailored screening strategies...
Methylation-specific PCR unraveledSarah Derks
Research Institute GROW, Department of Pathology, University Maastricht, PO Box 616, 6200 MD Maastricht, The Netherlands
Cell Oncol 26:291-9. 2004..This review discusses the critical parameters of MSP and presents an overview of the available MSP variants and the (clinical) applications...
Dual targeting of epigenetic therapy in cancerDebby M E I Hellebrekers
Tumor Biology Laboratory, Research Institute for Growth and Development GROW, Department of Pathology, Maastricht University and University Hospital Maastricht, Maastricht, The Netherlands
Biochim Biophys Acta 1775:76-91. 2007..Here we review the therapeutic potential of DNMT and HDAC inhibitors as anti-cancer drugs, as evaluated in clinical trials, and their angiostatic activities, apart from their inhibitory effects on tumor cells...
Comprehensive mutation analysis in colorectal flat adenomasQuirinus J M Voorham
Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
PLoS ONE 7:e41963. 2012..In the present study, we aimed to compare the mutation spectrum of 14 cancer genes, between these two phenotypes...
Promoter methylation precedes chromosomal alterations in colorectal cancer developmentSarah Derks
Department of Pathology, Research Institute GROW, University Maastricht, The Netherlands
Cell Oncol 28:247-57. 2006....
Loss of SerpinA5 protein expression is associated with advanced-stage serous ovarian tumorsIngrid T G W Bijsmans
Department of Pathology, GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands
Mod Pathol 24:463-70. 2011....
Pharmacoepigenomics in colorectal cancer: a step forward in predicting prognosis and treatment responseKim M Smits
Department of Epidemiology, GROW School for Oncology and Developmental Biology, Maastricht University, The Netherlands
Pharmacogenomics 9:1903-16. 2008..This review describes the current knowledge on the prognostic and predictive value of epigenetic markers in colorectal cancer...
The N-myc downstream regulated gene (NDRG) family: diverse functions, multiple applicationsVeerle Melotte
Department of Pathology, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands
FASEB J 24:4153-66. 2010..Finally, their role in disease and potential clinical applications (their role as detection or prognostic markers) are discussed...
Molecular tests for colorectal cancer screeningLinda J W Bosch
Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
Clin Colorectal Cancer 10:8-23. 2011..Evaluation in large well-controlled randomized trials is the next step needed to take molecular markers for CRC screening to the next level and warrant implementation in a screening setting...
Body size and risk for colorectal cancers showing BRAF mutations or microsatellite instability: a pooled analysisLaura A E Hughes
Department of Epidemiology, GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands
Int J Epidemiol 41:1060-72. 2012..We investigated whether measures of anthropometry differentially influence risk of tumours according to BRAF c.1799T>A p.V600E mutation (BRAF) and microsatellite instability (MSI) status...
Epigenetic changes in Basal Cell Carcinoma affect SHH and WNT signaling componentsTjinta Brinkhuizen
Department of Dermatology, Maastricht University Medical Center, Maastricht, The Netherlands
PLoS ONE 7:e51710. 2012..Epigenetic alterations such as promoter hypermethylation silence tumor suppressor genes (TSG) in several malignancies...
Genetics and epigenetics of renal cell cancerMarcella M L Baldewijns
Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands
Biochim Biophys Acta 1785:133-55. 2008..In this review we discuss the background of RCC and the clinical applications of RCC genetics and epigenetics...
Angiostatic activity of DNA methyltransferase inhibitorsDebby M E I Hellebrekers
Angiogenesis Laboratory, Research Institute for Growth and Development, Department of Pathology, Maastricht University and University Hospital, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands
Mol Cancer Ther 5:467-75. 2006..In conclusion, our data show that DNMT inhibitors have angiostatic activity in addition to their inhibitory effects on tumor cells. This dual action of these compounds makes them promising anticancer therapeutics...
Differential gene expression in ovarian tumors reveals Dusp 4 and Serpina 5 as key regulators for benign behavior of serous borderline tumorsNathalie L G Sieben
Department of Pathology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
J Clin Oncol 23:7257-64. 2005..The purpose of this study was to further unravel the genetic pathways through which SBTs develop, with a special focus on explaining the generally benign SBT behavior. Materials and..
Genetics and epigenetics of cutaneous malignant melanoma: a concert out of tuneKarin van den Hurk
Department of Pathology, Maastricht University Medical Centre, Maastricht, The Netherlands
Biochim Biophys Acta 1826:89-102. 2012..Importantly, we point out that it is this interplay of genetics and epigenetics that effectively leads to distorted gene expression patterns in CMM...
Taxane resistance in breast cancer: a closed HER2 circuit?Joep P J de Hoon
Division of Medical Oncology, Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands
Biochim Biophys Acta 1825:197-206. 2012..In conclusion, taxane resistance in breast cancer follows a multiplex establishment of drug cytotoxicity escape routes, which may be most efficiently therapeutically targeted by interference with their mutually governing signaling nodes...
Characteristics of triple-negative breast cancerTim C de Ruijter
Division of Medical Oncology, Department of Internal Medicine, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, P O Box 5800, 6202 AZ Maastricht, The Netherlands
J Cancer Res Clin Oncol 137:183-92. 2011..The purpose of this review is to summarise the latest findings on TNBC concerning its relation and delineation to BBC, discuss the developmental pathways involved and address clinical implications for this complex type of breast cancer...
K-ras mutations and RASSF1A promoter methylation in colorectal cancerManon van Engeland
Department of Pathology, University Maastricht, P O Box 616 6200 MD Maastricht, The Netherlands
Oncogene 21:3792-5. 2002..These data show that the majority of the studied CRCs with K-ras mutations lack RASSF1A promoter methylation, an event which occurs predominantly in K-ras wild-type CRCs (P=0.023, Chi-square test)...
